Company & Sponsor Intelligence

University of Virginia

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting4

Completed2

Countries2

Therapeutic footprint

adhdalzheimersautismepilepsymovement_disordersmultiple_sclerosisother_neurologyparkinsons

Indexed studies

NCT00572026Enhancing ADHD Driving Performance With Stimulant Medication
adhd · United StatesNA

NCT05018169Behavioral Activation for Treatment of Depression in Adolescents With Autism
autism · United StatesNA

NCT06623994Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
epilepsy · KenyaNA

NCT05565833Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
alzheimers · United StatesPHASE2

NCT03718247Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS
multiple_sclerosis · United StatesCOMPLETED

NCT04495686An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury
alzheimers · United StatesNA

NCT06257069Tremor Retrainer Software Application for Functional Tremor
movement_disorders · United StatesNA

NCT07213648Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
parkinsons · United StatesNA

NCT04192149The Effects of Ultrasound on Central Nervous System
other_neurology · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →